{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:00:22Z","timestamp":1784239222315,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bristol-Myers-Squibb and Pfizer, Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ygyno.2020.06.505","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T23:17:07Z","timestamp":1593991027000},"page":"754-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: A subanalysis"],"prefix":"10.1016","volume":"158","author":[{"given":"Megan E.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyse","family":"Brennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tayebnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saketh R.","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.06.505_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: a review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamasurg.2013.3172","article-title":"Venous thromboembolism after major cancer surgery: temporal trends and patterns of care","volume":"149","author":"Trinh","year":"2014","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0020","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1245\/s10434-008-0151-4","article-title":"Venous thromboembolism in cancer patients undergoing major surgery","volume":"15","author":"Osborne","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/2051415815606847","article-title":"Post-operative use of low molecular weight heparin: are patients doing their bit?","volume":"9","author":"Hardy","year":"2016","journal-title":"J. Clin. Urol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0040","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11605-018-3936-1","article-title":"Dabigatran (Pradaxa) is safe for extended venous thromboembolism prophylaxis after surgery for pancreatic cancer","volume":"23","author":"Rashid","year":"2019","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1378\/chest.14-0402","article-title":"Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis","volume":"147","author":"Vedovati","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for post-operative venous thromboembolism prevention in women undergoing surgery for gynecologic malignancy: a randomized clinical trial","author":"Guntupalli","year":"2020","journal-title":"JAMA Open Network"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1186\/s40064-016-2724-1","article-title":"The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery","volume":"5","author":"Gao","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213432","article-title":"Temporal effectiveness of interventions to improve medication adherence: a network meta-analysis","volume":"14","author":"Wiecek","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0070","author":"Optum. SF-8 Health Survey"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0075","series-title":"National Comorbidity Survey (NCS)","author":"School","year":"2007"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0080","series-title":"ZIP code database","author":"Service USP","year":"2020"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179272","article-title":"Estimating an area-level socioeconomic status index and its association with colonoscopy screening adherence","volume":"12","author":"Wheeler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5144\/0256-4947.2004.221","article-title":"Adherence to long-term therapies: evidence for action","volume":"24","author":"Chaudri","year":"2004","journal-title":"Annal. Saudi Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0095","first-page":"984","article-title":"Preoperative depression and hospital length of stay in surgical patients","volume":"80","author":"Kerper","year":"2014","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0100","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/gerona\/60.12.1563","article-title":"Are preoperative depressive symptoms associated with postoperative delirium in geriatric surgical patients?","volume":"60","author":"Leung","year":"2005","journal-title":"J. Gerontol. Series A: Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.24015\/JAPM.2017.0081","article-title":"Patient-reported outcome measures (PROM) as a preoperative assessment tool","volume":"4","author":"Kim","year":"2017","journal-title":"J. Anesth. Perioper. Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.amjcard.2014.05.058","article-title":"Relation of major depression to survival after coronary artery bypass grafting","volume":"114","author":"Stenman","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12893-016-0120-y","article-title":"Depression and postoperative complications: an overview","volume":"16","author":"Ghoneim","year":"2016","journal-title":"BMC Surg."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12872-020-01378-4","article-title":"Longitudinal study of the relationship between patients\u2019 medication adherence and quality of life outcomes and illness perceptions and beliefs about cardiac rehabilitation","volume":"20","author":"Thomson","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canep.2014.03.012","article-title":"Adherence influencing factors in patients taking oral anticancer agents: a systematic review","volume":"38","author":"Mathes","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11136-018-2060-8","article-title":"Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey","volume":"28","author":"Khayyat","year":"2019","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.04.002","article-title":"Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?","volume":"133","author":"Doll","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2019-000555","article-title":"African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type","author":"Whitmore","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0145","first-page":"1071","article-title":"Race and medication adherence in Medicaid enrollees with type-2 diabetes","volume":"98","author":"Shenolikar","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0150","series-title":"Quick Facts","author":"Bureau USC","year":"2019"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy5020020","article-title":"Quality of life and medication adherence of independently living older adults enrolled in a pharmacist-based medication management program","volume":"5","author":"Harlow","year":"2017","journal-title":"Pharmacy"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212117","article-title":"Racial and ethnic disparities in medication adherence among privately insured patients in the United States","volume":"14","author":"Xie","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-072X-11-48","article-title":"Medication deserts: survey of neighborhood disparities in availability of prescription medications","volume":"11","author":"Amstislavski","year":"2012","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","article-title":"Traveling towards disease: transportation barriers to health care access","volume":"38","author":"Syed","year":"2013","journal-title":"J. Community Health"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0175","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0180","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1913808","article-title":"Rivaroxaban or enoxaparin in nonmajor orthopedic surgery","volume":"382","author":"Samama","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2016.06.005","article-title":"Low-molecular-weight heparins for cancer-associated thrombosis: adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study","volume":"144","author":"Cajfinger","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ygyno.2020.06.505_bb0190","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3324\/haematol.2015.127126","article-title":"Assessing patients\u2019 anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology","volume":"100","author":"Noble","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.ygyno.2020.06.505_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","article-title":"Patient compliance with outpatient prophylaxis: an observational study","volume":"28","author":"Colwell","year":"2005","journal-title":"Orthopedics"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:53:29Z","timestamp":1758772409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820323313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0090825820323313"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.505","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: A subanalysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}